Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 4 1Phase 2/3 1Phase 1/2 1

Status

Terminated 3Completed 2

Sponsor Class

INDUSTRY 8OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Endocrine 4NET 2Gastrointestinal 2Tumor-Agnostic 1

Conditions

Carcinoid Tumor 2Pituitary Neoplasms 1Neuroendocrine Tumors 1Neoplasm Metastasis 1Gigantism 1Gastrointestinal Neoplasms 1Gastro-enteropancreatic neuroendocrine tumor 1Acromegaly 1

Interventions

Cyclophosphamide 548pembrolizumab 385Radiotherapy 363Bevacizumab 360Carboplatin 351Rituximab 315Cisplatin 300Gemcitabine 297Paclitaxel 288Dexamethasone 272Docetaxel 271fludarabine phosphate 241Doxorubicin 231Nivolumab 220Etoposide 209Cytarabine 203Lenalidomide 201fludarabine 191Oxaliplatin 191Fluorouracil 190Melphalan 189Filgrastim 188Capecitabine 175Calcium Dobesilate 172Radiosurgery 167Erlotinib Hydrochloride 167Methotrexate 163Bortezomib 162Granulocyte Colony-Stimulating Factor 154Whole-Body Irradiation 144

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
OTHER × Has results × lanreotide × Clear all
NCT02795858 2025-02-19

A Phase II Study of Ramucirumab With Somatostatin Analog Therapy in Patients With Advanced, Progressive Carcinoid Tumors

Dana-Farber Cancer Institute

Phase 2 Completed
43 enrolled 11 charts
Endocrine

Carcinoid Tumor

NCT02859064 2023-12-05

Study of Lanreotide in Patients With Metastatic Gastrointestinal Neuroendocrine Tumors Who Are Undergoing Liver-directed Radioembolization With Yttrium-90 Microspheres

SCRI Development Innovations, LLC

Phase 2 Terminated
6 enrolled 12 charts
EndocrineGastrointestinalNET

Carcinoid Tumor, Gastrointestinal Neoplasms, Neuroendocrine Tumors

NCT03043664 2023-06-29

PLANET

Duke University

Phase 1/2 Completed
22 enrolled 12 charts
EndocrineGastrointestinalNET

Gastro-enteropancreatic neuroendocrine tumor

NCT02288377 2023-01-18

REMINET

Federation Francophone de Cancerologie Digestive

Phase 2/3 Terminated
53 enrolled 11 charts
Tumor-Agnostic

Neoplasm Metastasis

NCT01861717 2021-09-30

A Pilot Study of Pre- and Post-operative Use of Somatuline Depot.

Saint John's Cancer Institute

Phase 4 Terminated
4 enrolled 5 charts
Endocrine

Acromegaly, Gigantism, Pituitary Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡